ZYKADIA
Live / Registered — Registered and renewed (as of 19 Jun 2025)
What this means for you
Registered since 01 Sept 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Sept 2025).
Record
- Serial number
- 86036708
- Registration number
- 4804580
- Mark type
- Stylized text
- Filed
- 13 Aug 2013
- Published for opposition
- 07 Jan 2014
- Registered
- 01 Sept 2015
- Next maintenance due
- 01 Sept 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer excluding pharmaceutical preparations for the treatment of sleep disorders or neurological disorders
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 19 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Jun 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Jun 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Jan 2025 — TEAS SECTION 8 & 9 RECEIVED
- 01 Sept 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 May 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 May 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 May 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Jan 2021 — TEAS SECTION 8 & 15 RECEIVED
- 01 Sept 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Sept 2015 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Jul 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jul 2015 — STATEMENT OF USE PROCESSING COMPLETE